Citation Tools

Download PDFPDF
CP-061 Long-term cost-effectiveness analysis of infliximab, etanercept and adalimumab in rheumatoid arthritis patients in real-life clinical practice

Download to a citation manager

Cite this article as:
Cardenas M, Font P, De La Fuente-Ruiz S, et al
CP-061 Long-term cost-effectiveness analysis of infliximab, etanercept and adalimumab in rheumatoid arthritis patients in real-life clinical practice